Maternal satisfaction with a novel filtered-sunlight phototherapy for newborn jaundice in Southwest Nigeria

BMC Pediatrics

Tina M Slusher¹  Abieyuwa A Emokpae²  Cecilia A Mabogunje²  Zainab O Imam²  Bolajoko O Olusanya³ 

[1] Department of Pediatrics, University of Minnesota and Hennepin County Medical Center, Minneapolis, MN 55415, USA;Massey Street Children’s Hospital, Lagos, Nigeria;Centre for Healthy Start Initiative, 286A Corporation Drive, Dolphin Estate Ikoyi, Lagos, Nigeria

关键词: Developing country;    Phototherapy;    Patient satisfaction;    Sunlight exposure;    Newborn care;    Neonatal jaundice;   

Others  :  839901
DOI  :  10.1186/1471-2431-14-180

 received in 2014-05-12, accepted in 2014-07-03,  发布年份 2014

【 摘 要 】

Background

In many resource-limited settings, the availability of effective phototherapy for jaundiced infants is frequently hampered by lack of, or inadequate resources to acquire and maintain conventional electric-powered phototherapy devices. This study set out to ascertain maternal experience and satisfaction with a novel treatment of infants with significant hyperbilirubinemia using filtered sunlight phototherapy (FSPT) in a tropical setting with irregular access to effective conventional phototherapy.

Methods

A cross-sectional satisfaction survey was conducted among mothers of jaundiced infants treated with FSPT in an inner-city maternity hospital in Lagos, Nigeria from November 2013 to March 2014. Mothers’ experience during treatment was elicited with a pretested questionnaire consisting of closed and open-ended items. Satisfaction was rated on a five-point Likert scale. Correlates of overall maternal satisfaction were explored with descriptive and inferential non-parametric statistics.

Results

A total of 191 mothers were surveyed, 77 (40%) of whom had no prior knowledge of neonatal jaundice. Maternal satisfaction was highest for quality of nursing care received (mean: 4.72 ± 0.55, median: 5[IQR: 5–5]) and lowest for physical state of the test environment (mean: 3.85 ± 0.74, median: 4[IQR: 3–4]). The overall rating (mean: 4.17 ± 0.58, median: 4[IQR: 4–5]) and the observed effect of FSPT on the babies (mean: 4.34 ± 0.58, 4[IQR: 4–5]) were quite satisfactory. FSPT experience was significantly correlated with the adequacy of information received (p < 0.0005), test environment (p = 0.002) and the observed effect of FSPT on the child (p < 0.0005). Almost all mothers (98.4%) indicated willingness to use FSPT in future or recommend it to others, although some (30 or 15.7%) disliked the idea of exposing newborns to sunlight.

Conclusions

Mothers of jaundiced newborns in this population are likely to be satisfied with FSPT where it is inevitable as an alternative to conventional electric-powered phototherapy. Adequate information, good test environment and friendly nursing care must be ensured for satisfactory maternal experience.

【 授权许可】

   
2014 Olusanya et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]The Young Infants Clinical Signs Study Group: Clinical signs that predict severe illness in children under age 2 months: a multicentre study. Lancet 2008, 371:135-142.
• [2]Burke BL, Robbins JM, Bird TM, Hobbs CA, Nesmith C, Tilford JM: Trends in hospitalizations for neonatal jaundice and kernicterus in the United States, 1988–2005. Pediatrics 2009, 123:524-532.
• [3]Bhutani VK, Committee on Fetus and Newborn; American Academy of Pediatrics: Phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2011, 128:e1046-e1052.
• [4]Maisels MJ, McDonagh AF: Phototherapy for neonatal jaundice. N Engl J Med 2008, 358:920-928.
• [5]Bhutani VK, Cline BK, Donaldson KM, Vreman HJ: The need to implement effective phototherapy in resource-constrained settings. Semin Perinatol 2011, 35:192-197.
• [6]Cline BK, Vreman HJ, Faber K, Lou H, Donaldson KM, Amuabunosi E, Ofovwe G, Bhutani VK, Olusanya BO, Slusher TM: Phototherapy device effectiveness in Nigeria: irradiance assessment and potential for improvement. J Trop Pediatr 2013, 59:321-325.
• [7]Owa JA, Ogunlesi TA: Why we are still doing so many exchange blood transfusion for neonatal jaundice in Nigeria. World J Pediatr 2009, 5:51-55.
• [8]Petrova A, Mehta R, Birchwood G, Ostfeld B, Hegyi T: Management of neonatal hyperbilirubinemia: pediatricians’ practices and educational needs. BMC Pediatr 2006, 6:6.
• [9]Harrison SL, Buettner PG, MacLennan R: Why do mothers still sun their infants? J Paediatr Child Health 1999, 35:296-299.
• [10]Boo NY, Gan CY, Gian YW, Lim KS, Lim MW, Krishna-Kumar H: Malaysian mothers’ knowledge & practices on care of neonatal jaundice. Med J Malaysia 2011, 66:239-243.
• [11]Okperi BO: Neonatal jaundice and birth asphyxia as major causes of cerebral palsy in Nigeria: are doctors’ wrong beliefs and practices part of the problem? Int J Med Biomed Res 2013, 2:226-230.
• [12]Egube BA, Ofili AN, Isara AR, Onakewhor JU: Neonatal jaundice and its management: knowledge, attitude, and practice among expectant mothers attending antenatal clinic at University of Benin Teaching Hospital, Benin City, Nigeria. Niger J Clin Pract 2013, 16:188-194.
• [13]Vreman HJ, Slusher TM, Wong RJ, Schulz S, Olusanya BO, Stevenson DK: Evaluation of window-tinting films for sunlight phototherapy. J Trop Pediatr 2013, 59:496-501.
• [14]Slusher TM, Vreman HJ, Olusanya BO, Wong RJ, Brearley AM, Vaucher YE, Stevenson DK: Novel treatment of neonatal jaundice: safety and efficacy of filtered sunlight in African neonates. Pediatrics 2014, 133:e1568-e1574.
• [15]Slusher TM, Olusanya BO, Vreman HJ, Wong RJ, Brearley AM, Vaucher YE, Stevenson DK: Treatment of neonatal jaundice with filtered sunlight in Nigerian neonates: study protocol of a non-inferiority, randomized controlled trial. Trials 2013, 14:446.
• [16]Pascoe GC: Patient satisfaction in primary health care: a literature review and analysis. Eval Program Plann 1983, 6:185-210.
• [17]Ezeaka CV, Ugwu RO, Mukhtar-Yola M, Ekure EN, Olusanya BO: Pattern and predictors of maternal care-seeking practices for severe neonatal jaundice in Nigeria: a multi-centre survey. BMC Health Serv Res 2014, 14:192.
• [18]Kelley K, Clark B, Brown V, Sitzia J: Good practice in the conduct and reporting of survey research. Int J Qual Health Care 2003, 15:261-266.
• [19]Sitzia J: How valid and reliable are patient satisfaction data? An analysis of 195 studies. Int J Qual Health Care 1999, 11:319-328.
• [20]Harrison S, Nowak M, Devine S, Saunders V, Smith A, Buettner P: An intervention to discourage Australian mothers from unnecessarily exposing their babies to the sun for therapeutic reasons. J Trop Pediatr 2013, 59:403-406.
• [21]Devine SG, Harrison SL, Buettner PG: Building capacity of maternity staff to discourage the use of sunlight therapy in the post-partum period and infancy. Women Birth 2008, 21:107-111.
• [22]Aladag N, Filiz TM, Topsever P, Gorpelioglu S: Parents’ knowledge and behaviour concerning sunning their babies; a cross-sectional, descriptive study. BMC Pediatr 2006, 6:27.
• [23]National Institute for Health and Clinical Excellence: Neonatal jaundice. (Clinical guideline 98.). 2010. http://www.nice.org.uk/CG98
• [24]American Academy of Pediatrics (AAP): Management of hyperbilirubinaemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004, 114:297-316.
• [25]National Neonatal Forum, India: Management of neonatal hyperbilirubinemia. 2014. Available at: http://www.nnfpublication.org [Accessed May 6, 2014]
• [26]Queensland Maternity and Neonatal Clinical Guidelines: Neonatal jaundice. Queensland Government, Australia. 2012. Available at: http://www.health.qld.gov.au/qcg/documents/g_jaundice.pdf [Accessed on May 6, 2014]
• [27]Ministry of Health: Neonatal Jaundice: problems of the newborn in Standard Treatment Guidelines, Sixth edition. Republic of Ghana: Ministry of Health; 2010.
• [28]Rasul CH, Hasan MA, Yasmin F: Outcome of neonatal hyperbilirubinemia in a tertiary care hospital in Bangladesh. Malays J Med Sci 2010, 17:40-44.